{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T13:26:37Z","timestamp":1793366797566,"version":"4.5.0"},"reference-count":63,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2025,1,28]],"date-time":"2025-01-28T00:00:00Z","timestamp":1738022400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,1,28]],"date-time":"2025-01-28T00:00:00Z","timestamp":1738022400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Biotechnol"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1038\/s41587-024-02524-5","type":"journal-article","created":{"date-parts":[[2025,1,28]],"date-time":"2025-01-28T05:04:17Z","timestamp":1738040657000},"page":"1996-2008","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":18,"title":["A human metabolic map of pharmacological perturbations reveals drug modes of action"],"prefix":"10.1038","volume":"43","author":[{"ORCID":"https:\/\/orcid.org\/0009-0008-4175-6660","authenticated-orcid":false,"given":"Laurentz","family":"Schuhknecht","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0603-1073","authenticated-orcid":false,"given":"Karin","family":"Ortmayr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J\u00fcrgen","family":"J\u00e4nes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-3702-3644","authenticated-orcid":false,"given":"Martina","family":"Bl\u00e4si","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-1202-6037","authenticated-orcid":false,"given":"Eleni","family":"Panoussis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sebastian","family":"Bors","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-2137-5533","authenticated-orcid":false,"given":"Ter\u00e9zia","family":"Dor\u010d\u00e1kov\u00e1","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5006-6874","authenticated-orcid":false,"given":"Tobias","family":"Fuhrer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pedro","family":"Beltrao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9339-068X","authenticated-orcid":false,"given":"Mattia","family":"Zampieri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,1,28]]},"reference":[{"key":"2524_CR1","doi-asserted-by":"publisher","first-page":"11178","DOI":"10.1073\/pnas.1204524109","volume":"109","author":"E Gregori-Puigjan\u00e9","year":"2012","unstructured":"Gregori-Puigjan\u00e9, E. et al. Identifying mechanism-of-action targets for drugs and probes. Proc. Natl Acad. Sci. USA 109, 11178\u201311183 (2012).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"2524_CR2","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1038\/s41573-020-0087-3","volume":"20","author":"CH Emmerich","year":"2021","unstructured":"Emmerich, C. H. et al. Improving target assessment in biomedical research: the GOT-IT recommendations. Nat. Rev. Drug Discov. 20, 64\u201381 (2021).","journal-title":"Nat. Rev. Drug Discov."},{"key":"2524_CR3","doi-asserted-by":"publisher","first-page":"899","DOI":"10.1038\/s41573-022-00472-w","volume":"21","author":"F Vincent","year":"2022","unstructured":"Vincent, F. et al. Phenotypic drug discovery: recent successes, lessons learned and new directions. Nat. Rev. Drug Discov. 21, 899\u2013914 (2022).","journal-title":"Nat. Rev. Drug Discov."},{"key":"2524_CR4","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1038\/nrd.2017.111","volume":"16","author":"JG Moffat","year":"2017","unstructured":"Moffat, J. G., Vincent, F., Lee, J. A., Eder, J. & Prunotto, M. Opportunities and challenges in phenotypic drug discovery: an industry perspective. Nat. Rev. Drug Discov. 16, 531\u2013543 (2017).","journal-title":"Nat. Rev. Drug Discov."},{"key":"2524_CR5","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1038\/s43018-019-0018-6","volume":"1","author":"SM Corsello","year":"2020","unstructured":"Corsello, S. M. et al. Discovering the anticancer potential of non-oncology drugs by systematic viability profiling. Nat. Cancer 1, 235\u2013248 (2020).","journal-title":"Nat. Cancer"},{"key":"2524_CR6","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-27329-x","volume":"12","author":"T Pemovska","year":"2021","unstructured":"Pemovska, T. et al. Metabolic drug survey highlights cancer cell dependencies and vulnerabilities. Nat. Commun. 12, 7190 (2021).","journal-title":"Nat. Commun."},{"key":"2524_CR7","doi-asserted-by":"publisher","first-page":"1437","DOI":"10.1016\/j.cell.2017.10.049","volume":"171","author":"A Subramanian","year":"2017","unstructured":"Subramanian, A. et al. A next generation Connectivity Map: L1000 platform and the first 1,000,000 profiles. Cell 171, 1437\u20131452 (2017).","journal-title":"Cell"},{"key":"2524_CR8","doi-asserted-by":"publisher","first-page":"911","DOI":"10.1016\/j.cels.2022.10.001","volume":"13","author":"GP Way","year":"2022","unstructured":"Way, G. P. et al. Morphology and gene expression profiling provide complementary information for mapping cell state. Cell Syst. 13, 911\u2013923 (2022).","journal-title":"Cell Syst."},{"key":"2524_CR9","doi-asserted-by":"publisher","first-page":"845","DOI":"10.1038\/s41587-022-01539-0","volume":"41","author":"DC Mitchell","year":"2023","unstructured":"Mitchell, D. C. et al. A proteome-wide atlas of drug mechanism of action. Nat. Biotechnol. 41, 845\u2013857 (2023).","journal-title":"Nat. Biotechnol."},{"key":"2524_CR10","doi-asserted-by":"publisher","first-page":"846","DOI":"10.1038\/s41587-021-00860-4","volume":"39","author":"CB Messner","year":"2021","unstructured":"Messner, C. B. et al. Ultra-fast proteomics with Scanning SWATH. Nat. Biotechnol. 39, 846\u2013854 (2021).","journal-title":"Nat. Biotechnol."},{"key":"2524_CR11","doi-asserted-by":"crossref","unstructured":"Anglada-Girotto, M. et al. Combining CRISPRi and metabolomics for functional annotation of compound libraries. Nat. Chem. Biol. 18, 482\u2013491 (2022).","DOI":"10.1038\/s41589-022-00970-3"},{"key":"2524_CR12","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1126\/science.ade3925","volume":"380","author":"J Zecha","year":"2023","unstructured":"Zecha, J. et al. Decrypting drug actions and protein modifications by dose- and time-resolved proteomics. Science 380, 93\u2013101 (2023).","journal-title":"Science"},{"key":"2524_CR13","doi-asserted-by":"publisher","first-page":"e1005335","DOI":"10.1371\/journal.pcbi.1005335","volume":"13","author":"TM Filzen","year":"2017","unstructured":"Filzen, T. M., Kutchukian, P. S., Hermes, J. D., Li, J. & Tudor, M. Representing high throughput expression profiles via perturbation barcodes reveals compound targets. PLoS Comput. Biol. 13, e1005335 (2017).","journal-title":"PLoS Comput. Biol."},{"key":"2524_CR14","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1038\/nrd2876","volume":"8","author":"Y Feng","year":"2009","unstructured":"Feng, Y., Mitchison, T. J., Bender, A., Young, D. W. & Tallarico, J. A. Multi-parameter phenotypic profiling: using cellular effects to characterize small-molecule compounds. Nat. Rev. Drug Discov. 8, 567\u2013578 (2009).","journal-title":"Nat. Rev. Drug Discov."},{"key":"2524_CR15","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1038\/nbt.3419","volume":"34","author":"J Kang","year":"2016","unstructured":"Kang, J. et al. Improving drug discovery with high-content phenotypic screens by systematic selection of reporter cell lines. Nat. Biotechnol. 34, 70\u201377 (2016).","journal-title":"Nat. Biotechnol."},{"key":"2524_CR16","doi-asserted-by":"publisher","first-page":"100413","DOI":"10.1016\/j.crmeth.2023.100413","volume":"3","author":"BA Badwan","year":"2023","unstructured":"Badwan, B. A. et al. Machine learning approaches to predict drug efficacy and toxicity in oncology. Cell Rep. Methods 3, 100413 (2023).","journal-title":"Cell Rep. Methods"},{"key":"2524_CR17","doi-asserted-by":"publisher","first-page":"eaat9931","DOI":"10.1126\/science.aat9931","volume":"363","author":"M Zimmermann","year":"2019","unstructured":"Zimmermann, M., Zimmermann-Kogadeeva, M., Wegmann, R. & Goodman, A. L. Separating host and microbiome contributions to drug pharmacokinetics and toxicity. Science 363, eaat9931 (2019).","journal-title":"Science"},{"key":"2524_CR18","doi-asserted-by":"publisher","first-page":"835","DOI":"10.1016\/j.ccell.2022.06.010","volume":"40","author":"E Gon\u00e7alves","year":"2022","unstructured":"Gon\u00e7alves, E. et al. Pan-cancer proteomic map of 949 human cell lines. Cancer Cell 40, 835\u2013849 (2022).","journal-title":"Cancer Cell"},{"key":"2524_CR19","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-17336-9","volume":"11","author":"M Frejno","year":"2020","unstructured":"Frejno, M. et al. Proteome activity landscapes of tumor cell lines determine drug responses. Nat. Commun. 11, 3639 (2020).","journal-title":"Nat. Commun."},{"key":"2524_CR20","doi-asserted-by":"publisher","first-page":"1511","DOI":"10.1126\/science.1160165","volume":"322","author":"AA Cohen","year":"2008","unstructured":"Cohen, A. A. et al. Dynamic proteomics of individual cancer cells in response to a drug. Science 322, 1511\u20131516 (2008).","journal-title":"Science"},{"key":"2524_CR21","doi-asserted-by":"publisher","first-page":"530","DOI":"10.1038\/415530a","volume":"415","author":"LJ van\u2019t Veer","year":"2002","unstructured":"van\u2019t Veer, L. J. et al. Gene expression profiling predicts clinical outcome of breast cancer. Nature 415, 530\u2013536 (2002).","journal-title":"Nature"},{"key":"2524_CR22","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1038\/s41586-019-1103-9","volume":"568","author":"FM Behan","year":"2019","unstructured":"Behan, F. M. et al. Prioritization of cancer therapeutic targets using CRISPR\u2013Cas9 screens. Nature 568, 511\u2013516 (2019).","journal-title":"Nature"},{"key":"2524_CR23","doi-asserted-by":"publisher","first-page":"100492","DOI":"10.1016\/j.xcrm.2021.100492","volume":"3","author":"EF Douglass","year":"2022","unstructured":"Douglass, E. F. et al. A community challenge for a pancancer drug mechanism of action inference from perturbational profile data. Cell Rep. Med. 3, 100492 (2022).","journal-title":"Cell Rep. Med."},{"key":"2524_CR24","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-39528-9","volume":"14","author":"NU Nair","year":"2023","unstructured":"Nair, N. U. et al. A landscape of response to drug combinations in non-small cell lung cancer. Nat. Commun. 14, 3830 (2023).","journal-title":"Nat. Commun."},{"key":"2524_CR25","doi-asserted-by":"publisher","first-page":"1213","DOI":"10.1038\/nbt.3052","volume":"32","author":"M Bansal","year":"2014","unstructured":"Bansal, M. et al. A community computational challenge to predict the activity of pairs of compounds. Nat. Biotechnol. 32, 1213\u20131222 (2014).","journal-title":"Nat. Biotechnol."},{"key":"2524_CR26","doi-asserted-by":"crossref","unstructured":"Duran-Frigola, M. et al. Extending the small-molecule similarity principle to all levels of biology with the Chemical Checker. Nat. Biotechnol. 38, 1087\u20131096 (2020)","DOI":"10.1038\/s41587-020-0502-7"},{"key":"2524_CR27","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-019-09695-9","volume":"10","author":"K Ortmayr","year":"2019","unstructured":"Ortmayr, K., Dubuis, S. & Zampieri, M. Metabolic profiling of cancer cells reveals genome-wide crosstalk between transcriptional regulators and metabolism. Nat. Commun. 10, 1841 (2019).","journal-title":"Nat. Commun."},{"key":"2524_CR28","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1038\/s42003-018-0111-x","volume":"1","author":"S Dubuis","year":"2018","unstructured":"Dubuis, S., Ortmayr, K. & Zampieri, M. A framework for large-scale metabolome drug profiling links coenzyme A metabolism to the toxicity of anti-cancer drug dichloroacetate. Commun. Biol. 1, 101 (2018).","journal-title":"Commun. Biol."},{"key":"2524_CR29","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1038\/nbt.4072","volume":"36","author":"E Brunk","year":"2018","unstructured":"Brunk, E. et al. Recon3D enables a three-dimensional view of gene variation in human metabolism. Nat. Biotechnol. 36, 272\u2013281 (2018).","journal-title":"Nat. Biotechnol."},{"key":"2524_CR30","doi-asserted-by":"publisher","first-page":"D608","DOI":"10.1093\/nar\/gkx1089","volume":"46","author":"DS Wishart","year":"2018","unstructured":"Wishart, D. S. et al. HMDB 4.0: the human metabolome database for 2018. Nucleic Acids Res. 46, D608\u2013D617 (2018).","journal-title":"Nucleic Acids Res."},{"key":"2524_CR31","doi-asserted-by":"publisher","first-page":"1291","DOI":"10.1016\/j.molcel.2019.04.001","volume":"74","author":"AI Campos","year":"2019","unstructured":"Campos, A. I. & Zampieri, M. Metabolomics-driven exploration of the chemical drug space to predict combination antimicrobial therapies. Mol. Cell 74, 1291\u20131303 (2019).","journal-title":"Mol. Cell"},{"key":"2524_CR32","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1016\/S1043-6618(89)80002-7","volume":"21","author":"F Blasi","year":"1989","unstructured":"Blasi, F., Sommariva, D., Cosentini, R., Cavaiani, B. & Fasoli, A. Bezafibrate inhibits HMG-CoA reductase activity in incubated blood mononuclear cells from normal subjects and patients with heterozygous familial hypercholesterolaemia. Pharmacol. Res. 21, 247\u2013254 (1989).","journal-title":"Pharmacol. Res."},{"key":"2524_CR33","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1007\/BF00562501","volume":"4","author":"J Elis","year":"1972","unstructured":"Elis, J. & Ra\u0161kov\u00e1, H. New indications for 6-azauridine treatment in man. A review. Eur. J. Clin. Pharmacol. 4, 77\u201381 (1972).","journal-title":"Eur. J. Clin. Pharmacol."},{"key":"2524_CR34","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1016\/j.bcp.2006.10.016","volume":"73","author":"D Gonz\u00e1lez-Arag\u00f3n","year":"2007","unstructured":"Gonz\u00e1lez-Arag\u00f3n, D., Ariza, J. & Villalba, J. M. Dicoumarol impairs mitochondrial electron transport and pyrimidine biosynthesis in human myeloid leukemia HL-60 cells. Biochem. Pharmacol. 73, 427\u2013439 (2007).","journal-title":"Biochem. Pharmacol."},{"key":"2524_CR35","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/cbdd.14256","volume":"102","author":"S Cao","year":"2023","unstructured":"Cao, S. et al. Tiratricol, a thyroid hormone metabolite, has potent inhibitory activity against human dihydroorotate dehydrogenase. Chem. Biol. Drug Des. 102, 1\u201313 (2023).","journal-title":"Chem. Biol. Drug Des."},{"key":"2524_CR36","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1038\/s41586-019-0917-9","volume":"566","author":"J Lyu","year":"2019","unstructured":"Lyu, J. et al. Ultra-large library docking for discovering new chemotypes. Nature 566, 224\u2013229 (2019).","journal-title":"Nature"},{"key":"2524_CR37","doi-asserted-by":"publisher","first-page":"8341","DOI":"10.1021\/jm300630p","volume":"55","author":"Y Diao","year":"2012","unstructured":"Diao, Y. et al. Discovery of diverse human dihydroorotate dehydrogenase inhibitors as immunosuppressive agents by structure-based virtual screening. J. Med. Chem. 55, 8341\u20138349 (2012).","journal-title":"J. Med. Chem."},{"key":"2524_CR38","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-021-91069-7","volume":"11","author":"G Chilingaryan","year":"2021","unstructured":"Chilingaryan, G. et al. Combination of consensus and ensemble docking strategies for the discovery of human dihydroorotate dehydrogenase inhibitors. Sci. Rep. 11, 11417 (2021).","journal-title":"Sci. Rep."},{"key":"2524_CR39","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1002\/pro.3784","volume":"29","author":"SD Wierbowski","year":"2020","unstructured":"Wierbowski, S. D., Wingert, B. M., Zheng, J. & Camacho, C. J. Cross-docking benchmark for automated pose and ranking prediction of ligand binding. Protein Sci. 29, 298\u2013305 (2020).","journal-title":"Protein Sci."},{"key":"2524_CR40","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1002\/jcc.21334","volume":"31","author":"O Trott","year":"2010","unstructured":"Trott, O. & Olson, A. J. AutoDock Vina: Improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading. J. Comput. Chem. 31, 455\u2013461 (2010).","journal-title":"J. Comput. Chem."},{"key":"2524_CR41","doi-asserted-by":"publisher","unstructured":"Corso, G. et al. Deep confident steps to new pockets: strategies for docking generalization. Preprint at arXiv https:\/\/doi.org\/10.48550\/arXiv.2402.18396 (2024).","DOI":"10.48550\/arXiv.2402.18396"},{"key":"2524_CR42","doi-asserted-by":"publisher","first-page":"6582","DOI":"10.1021\/jm300687e","volume":"55","author":"MM Mysinger","year":"2012","unstructured":"Mysinger, M. M., Carchia, M., Irwin, J. J. & Shoichet, B. K. Directory of useful decoys, enhanced (DUD-E): better ligands and decoys for better benchmarking. J. Med. Chem. 55, 6582\u20136594 (2012).","journal-title":"J. Med. Chem."},{"key":"2524_CR43","doi-asserted-by":"publisher","first-page":"4799","DOI":"10.1038\/s41596-021-00597-z","volume":"16","author":"BJ Bender","year":"2021","unstructured":"Bender, B. J. et al. A practical guide to large-scale docking. Nat. Protoc. 16, 4799\u20134832 (2021).","journal-title":"Nat. Protoc."},{"key":"2524_CR44","doi-asserted-by":"publisher","first-page":"1693","DOI":"10.1038\/s43018-023-00667-z","volume":"4","author":"H Hwangbo","year":"2023","unstructured":"Hwangbo, H., Patterson, S. C., Dai, A., Plana, D. & Palmer, A. C. Additivity predicts the efficacy of most approved combination therapies for advanced cancer. Nat. Cancer 4, 1693\u20131704 (2023).","journal-title":"Nat. Cancer"},{"key":"2524_CR45","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1038\/s41584-020-0371-y","volume":"16","author":"RS Hardy","year":"2020","unstructured":"Hardy, R. S., Raza, K. & Cooper, M. S. Therapeutic glucocorticoids: mechanisms of actions in rheumatic diseases. Nat. Rev. Rheumatol. 16, 133\u2013144 (2020).","journal-title":"Nat. Rev. Rheumatol."},{"key":"2524_CR46","doi-asserted-by":"publisher","first-page":"eabm4452","DOI":"10.1126\/scisignal.abm4452","volume":"15","author":"B Caratti","year":"2022","unstructured":"Caratti, B. et al. The glucocorticoid receptor associates with RAS complexes to inhibit cell proliferation and tumor growth. Sci. Signal. 15, eabm4452 (2022).","journal-title":"Sci. Signal."},{"key":"2524_CR47","doi-asserted-by":"publisher","first-page":"e595","DOI":"10.1016\/S2352-3026(17)30208-9","volume":"4","author":"B Snijder","year":"2017","unstructured":"Snijder, B. et al. Image-based ex-vivo drug screening for patients with aggressive haematological malignancies: interim results from a single-arm, open-label, pilot study. Lancet Haematol. 4, e595\u2013e606 (2017).","journal-title":"Lancet Haematol."},{"key":"2524_CR48","doi-asserted-by":"publisher","DOI":"10.15252\/msb.20199405","volume":"16","author":"E Gon\u00e7alves","year":"2020","unstructured":"Gon\u00e7alves, E. et al. Drug mechanism-of-action discovery through the integration of pharmacological and CRISPR screens. Mol. Syst. Biol. 16, e9405 (2020).","journal-title":"Mol. Syst. Biol."},{"key":"2524_CR49","doi-asserted-by":"publisher","first-page":"846","DOI":"10.15252\/msb.20156400","volume":"11","author":"M Breinig","year":"2015","unstructured":"Breinig, M., Klein, F. A., Huber, W. & Boutros, M. A chemical-genetic interaction map of small molecules using high-throughput imaging in cancer cells. Mol. Syst. Biol. 11, 846 (2015).","journal-title":"Mol. Syst. Biol."},{"key":"2524_CR50","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1038\/nbt1075","volume":"23","author":"D di Bernardo","year":"2005","unstructured":"di Bernardo, D. et al. Chemogenomic profiling on a genome-wide scale using reverse-engineered gene networks. Nat. Biotechnol. 23, 377\u2013383 (2005).","journal-title":"Nat. Biotechnol."},{"key":"2524_CR51","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.78012","volume":"11","author":"C Carraro","year":"2022","unstructured":"Carraro, C. et al. Decoding mechanism of action and sensitivity to drug candidates from integrated transcriptome and chromatin state. eLife 11, e78012 (2022).","journal-title":"eLife"},{"key":"2524_CR52","doi-asserted-by":"publisher","first-page":"1567","DOI":"10.1038\/nprot.2015.101","volume":"10","author":"H Franken","year":"2015","unstructured":"Franken, H. et al. Thermal proteome profiling for unbiased identification of direct and indirect drug targets using multiplexed quantitative mass spectrometry. Nat. Protoc. 10, 1567\u20131593 (2015).","journal-title":"Nat. Protoc."},{"key":"2524_CR53","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-18071-x","volume":"11","author":"I Piazza","year":"2020","unstructured":"Piazza, I. et al. A machine learning-based chemoproteomic approach to identify drug targets and binding sites in complex proteomes. Nat. Commun. 11, 4200 (2020).","journal-title":"Nat. Commun."},{"key":"2524_CR54","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-018-06500-x","volume":"9","author":"C Ye","year":"2018","unstructured":"Ye, C. et al. DRUG-seq for miniaturized high-throughput transcriptome profiling in drug discovery. Nat. Commun. 9, 4307 (2018).","journal-title":"Nat. Commun."},{"key":"2524_CR55","doi-asserted-by":"publisher","unstructured":"Sinha, S., Sinha, N. & Ruppin, E. Deep characterization of cancer drugs mechanism of action by integrating large-scale genetic and drug screens. Preprint at bioRxiv https:\/\/doi.org\/10.1101\/2022.10.17.512424 (2022).","DOI":"10.1101\/2022.10.17.512424"},{"key":"2524_CR56","doi-asserted-by":"publisher","first-page":"688","DOI":"10.1016\/j.cell.2020.01.021","volume":"180","author":"JM Stokes","year":"2020","unstructured":"Stokes, J. M. et al. A deep learning approach to antibiotic discovery. Cell 180, 688\u2013702 (2020).","journal-title":"Cell"},{"key":"2524_CR57","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1016\/j.cell.2020.12.021","volume":"184","author":"V Cappelletti","year":"2021","unstructured":"Cappelletti, V. et al. Dynamic 3D proteomes reveal protein functional alterations at high resolution in situ. Cell 184, 545\u2013559 (2021).","journal-title":"Cell"},{"key":"2524_CR58","doi-asserted-by":"publisher","first-page":"D457","DOI":"10.1093\/nar\/gkv1070","volume":"44","author":"M Kanehisa","year":"2016","unstructured":"Kanehisa, M., Sato, Y., Kawashima, M., Furumichi, M. & Tanabe, M. KEGG as a reference resource for gene and protein annotation. Nucleic Acids Res. 44, D457\u2013D462 (2016).","journal-title":"Nucleic Acids Res."},{"key":"2524_CR59","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1038\/ng.3728","volume":"49","author":"RA Okimoto","year":"2017","unstructured":"Okimoto, R. A. et al. Inactivation of Capicua drives cancer metastasis. Nat. Genet. 49, 87\u201396 (2017).","journal-title":"Nat. Genet."},{"key":"2524_CR60","doi-asserted-by":"publisher","first-page":"e10716","DOI":"10.15252\/msb.202110716","volume":"18","author":"K Ortmayr","year":"2022","unstructured":"Ortmayr, K. & Zampieri, M. Sorting-free metabolic profiling uncovers the vulnerability of fatty acid \u03b2-oxidation in in vitro quiescence models. Mol. Syst. Biol. 18, e10716 (2022).","journal-title":"Mol. Syst. Biol."},{"key":"2524_CR61","doi-asserted-by":"publisher","first-page":"3232","DOI":"10.1021\/ac500472c","volume":"86","author":"M Zimmermann","year":"2014","unstructured":"Zimmermann, M., Sauer, U. & Zamboni, N. Quantification and mass isotopomer profiling of \u03b1-keto acids in central carbon metabolism. Anal. Chem. 86, 3232\u20133237 (2014).","journal-title":"Anal. Chem."},{"key":"2524_CR62","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1111\/1467-9868.00346","volume":"64","author":"JD Storey","year":"2002","unstructured":"Storey, J. D. A direct approach to false discovery rates. J. R. Stat. Soc. Ser. B Stat. Methodol. 64, 479\u2013498 (2002).","journal-title":"J. R. Stat. Soc. Ser. B Stat. Methodol."},{"key":"2524_CR63","doi-asserted-by":"publisher","first-page":"7369","DOI":"10.3390\/molecules26237369","volume":"26","author":"J Sunseri","year":"2021","unstructured":"Sunseri, J. & Koes, D. R. Virtual screening with Gnina 1.0. Molecules 26, 7369 (2021).","journal-title":"Molecules"}],"container-title":["Nature Biotechnology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41587-024-02524-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41587-024-02524-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41587-024-02524-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,12]],"date-time":"2025-12-12T09:02:17Z","timestamp":1765530137000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41587-024-02524-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,28]]},"references-count":63,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2025,12]]}},"alternative-id":["2524"],"URL":"https:\/\/doi.org\/10.1038\/s41587-024-02524-5","relation":{},"ISSN":["1087-0156","1546-1696"],"issn-type":[{"value":"1087-0156","type":"print"},{"value":"1546-1696","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,1,28]]},"assertion":[{"value":"24 February 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 December 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 January 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}